Effect of Small Interfering RNA Targeting Wild-type FLT3 in Acute Myeloid Leukaemia Cells In Vitro and In Vivo

By Wang C-M   Sheng G-Y   Lu J   Xie L   Bai S-T   Xu X-J   Liu Y-F  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1661-1674

Field House Publishing

Access to resources Recommend Favorite

World Health Organization Sub-types, Initial Treatment Outcome and Prognostic Study of Unselected Adult Patients with Acute Myeloid Leukaemia in Shanghai: an Analysis of 623 Cases

By Ma Y   Wang X   Xu X   Lin G  

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 1191-1201

Field House Publishing

Access to resources Recommend Favorite

Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations

By Alvarado Yesid   Kantarjian Hagop M.   Luthra Rajyalakshmi   Ravandi Farhad   Borthakur Gautam   Garcia-Manero Guillermo   Konopleva Marina   Estrov Zeev   Andreeff Michael   Cortes Jorge E.  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2142-2149

Blackwell Publishing

Access to resources Recommend Favorite

Mitoxantrone: Acute myeloid leukaemia: 2 patients

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia

By Jønsson V.  

PharmacoEconomics, Vol. 15, Iss. 2, 1999-02 ,pp. : 167-178

Adis International

Access to resources Recommend Favorite